RE: Big dollar13 Feb 2016 11:38
Hi Lee, unlike OPTI things will move a little slower with EVG as with any clinical stage pharma company. My thoughts are they have only been listed ~4 months but have some exciting products, cash, solid management and appear to be recruiting some very experienced individuals. Things won't move quickly due to the clinical trials and regulations etc etc but I see good potential here and I have been averaging down from 30p. Personally I can't see the SP dropping too much further as it's worth far more and has been tipped at 70-80p. If you have patience and cash then I see EVG as a solid investment.